Latest Post

On Friday, January 13, the Supreme Court granted certiorari in Amgen v. Sandoz (Nos. 15-1039 & 15-1195). The Supreme Court originally deferred its decision on the parties’ certiorari petitions in order to consider the Solicitor General’s views. See prior post. On December 7, the Solicitor General filed a briefing recommending that certiorari be granted. See prior post. The case involves issues central to the application of the Biologics Price Competition and Innovation Act… Continue Reading